AAAAAA
Results:
1-25
|
Results: 25
Authors:
Kayser, O
Kolodziej, H
Kiderlen, AF
Citation: O. Kayser et al., Immunomodulatory principles of Pelargonium sidoides, PHYTOTHER R, 15(2), 2001, pp. 122-126
Authors:
Kayser, O
Kiderlen, AF
Citation: O. Kayser et Af. Kiderlen, In vitro leishmanicidal activity of naturally occurring chalcones, PHYTOTHER R, 15(2), 2001, pp. 148-152
Authors:
Kiderlen, AE
Kayser, O
Ferreira, D
Kolodziej, H
Citation: Ae. Kiderlen et al., Tannins and related compounds: Killing of amastigotes of Leishmania donovani and release of nitric oxide and tumour necrosis factor alpha in macrophages in vitro, Z NATURFO C, 56(5-6), 2001, pp. 444-454
Authors:
Kolodziej, H
Kayser, O
Kiderlen, AF
Ito, H
Hatano, T
Yoshida, T
Foo, LY
Citation: H. Kolodziej et al., Proanthocyanidins and related compounds: Antileishmanial activity and modulatory effects on nitric oxide and tumor necrosis factor-alpha-release in the murine macrophage-like cell line RAW 264.7, BIOL PHAR B, 24(9), 2001, pp. 1016-1021
Authors:
Jacobs, C
Kayser, O
Muller, RH
Citation: C. Jacobs et al., Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone, INT J PHARM, 214(1-2), 2001, pp. 3-7
Authors:
Kayser, O
Citation: O. Kayser, A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications, INT J PHARM, 214(1-2), 2001, pp. 83-85
Authors:
Gessner, A
Olbrich, C
Schroder, W
Kayser, O
Muller, RH
Citation: A. Gessner et al., The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles, INT J PHARM, 214(1-2), 2001, pp. 87-91
Authors:
Muller, RH
Jacobs, C
Kayser, O
Citation: Rh. Muller et al., Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future, ADV DRUG DE, 47(1), 2001, pp. 3-19
Authors:
Scholer, N
Krause, K
Kayser, O
Muller, RH
Borner, K
Hahn, H
Liesenfeld, O
Citation: N. Scholer et al., Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis, ANTIM AG CH, 45(6), 2001, pp. 1771-1779
Authors:
Kayser, O
Kiderlen, AF
Bertels, S
Siems, K
Citation: O. Kayser et al., Antileishmanial activities of aphidicolin and its semisynthetic derivatives, ANTIM AG CH, 45(1), 2001, pp. 288-292
Authors:
Kayser, O
Kiderlen, AF
Brun, R
Citation: O. Kayser et al., In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54, PLANTA MED, 67(8), 2001, pp. 718-721
Authors:
Kayser, O
Waters, WR
Woods, KM
Upton, SJ
Keithly, JS
Kiderlen, AF
Citation: O. Kayser et al., Evaluation of in vitro activity of aurones and related compounds against Cryptosporidium parvum, PLANTA MED, 67(8), 2001, pp. 722-725
Authors:
Latte, KP
Kayser, O
Tan, N
Kaloga, M
Kolodziej, H
Citation: Kp. Latte et al., Unusual coumarin patterns of Pelargonium species forming the origin of thetraditional herbal medicine umckaloabo, Z NATURFO C, 55(7-8), 2000, pp. 528-533
Authors:
Grau, MJ
Kayser, O
Muller, RH
Citation: Mj. Grau et al., Nanosuspensions of poorly soluble drugs - reproducibility of small scale production, INT J PHARM, 196(2), 2000, pp. 155-159
Authors:
Jacobs, C
Kayser, O
Muller, RH
Citation: C. Jacobs et al., Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide, INT J PHARM, 196(2), 2000, pp. 161-164
Authors:
Krause, KP
Kayser, O
Mader, K
Gust, R
Muller, RH
Citation: Kp. Krause et al., Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation, INT J PHARM, 196(2), 2000, pp. 169-172
Authors:
Kayser, O
Citation: O. Kayser, Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages, INT J PHARM, 196(2), 2000, pp. 253-256
Authors:
Loukaci, A
Kayser, O
Bindseil, KU
Siems, K
Frevert, J
Abreu, PM
Citation: A. Loukaci et al., New trichothecenes isolated from Holarrhena floribunda, J NAT PROD, 63(1), 2000, pp. 52-56
Authors:
Kayser, O
Kiderlen, AF
Laatsch, H
Croft, SL
Citation: O. Kayser et al., In vitro leishmanicidal activity of monomeric and dimeric naphthoquinones (vol 76, pg 131, 2000), ACT TROP, 77(3), 2000, pp. 305
Authors:
Kayser, O
Kiderlen, AF
Laatsch, H
Croft, SL
Citation: O. Kayser et al., In vitro leishmanicidal activity of monomeric and dimeric naphthoquinones, ACT TROP, 76(2), 2000, pp. 131-138
Authors:
Riordan, CE
Langreth, SG
Sanchez, LB
Kayser, O
Keithly, JS
Citation: Ce. Riordan et al., Preliminary evidence for a mitochondrion in Cryptosporidium parvum: Phylogenetic and therapeutic implications, J EUKAR MIC, 46(5), 1999, pp. 52S-55S
Authors:
Kayser, O
Kolodziej, H
Citation: O. Kayser et H. Kolodziej, Antibacterial activity of simple coumarins: Structural requirements for biological activity, Z NATURFO C, 54(3-4), 1999, pp. 169-174
Authors:
Meckes, A
Behrens, J
Kayser, O
Benecke, W
Becker, T
Muller, G
Citation: A. Meckes et al., Microfluidic system for the integration and cyclic operation of gas sensors, SENS ACTU-A, 76(1-3), 1999, pp. 478-483
Authors:
Kolodziej, H
Kayser, O
Latte, KP
Ferreira, D
Citation: H. Kolodziej et al., Evaluation of the antimicrobial potency of tannins and related compounds using the microdilution broth method, PLANTA MED, 65(5), 1999, pp. 444-446
Authors:
Kayser, O
Kiderlen, AF
Folkens, U
Kokodziej, H
Citation: O. Kayser et al., In vitro leishmanicidal activity of aurones, PLANTA MED, 65(4), 1999, pp. 316-319
Risultati:
1-25
|